Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
10.99
+0.29 (2.71%)
At close: May 12, 2025, 4:00 PM
10.99
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $945.66 million as of May 12, 2025. Its market cap has decreased by -46.46% in one year.
Market Cap
945.66M
Enterprise Value
781.86M
1-Year Change
-46.46%
Ranking
Category
Stock Price
$10.99
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $945.66M, an increase of 353.34%. That is a compound annual growth rate of 17.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 920.70M | -18.41% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.41B |
| Johnson & Johnson | 370.82B |
| UnitedHealth Group | 343.15B |
| AbbVie | 337.01B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.48B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |